Center for Translational Research in Aging & Longevity, Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, 4301 W. Markham St. Slot 806, Little Rock, AR 72205, USA.
Clin Nutr. 2011 Dec;30(6):759-68. doi: 10.1016/j.clnu.2011.05.008. Epub 2011 Jun 16.
Maintenance of muscle mass is crucial to improving outcome and quality of life in cancer patients. Stimulating muscle protein synthesis is the metabolic basis for maintaining muscle mass, but in cancer patients normal dietary intake has minimal effects on muscle protein synthesis. Adding leucine to high protein supplements stimulates muscle protein synthesis in healthy older subjects. The objective was to determine if a specially formulated medical food, high in leucine and protein, stimulates muscle protein synthesis acutely in individuals with cancer to a greater extent than a conventional medical food.
A randomized, controlled, double-blind, parallel-group design was used in 25 patients with radiographic evidence of cancer. Patients were studied before their cancer treatment was started or 4 weeks after their treatment was completed or halted. The fractional rate of muscle protein synthesis (FSR) was measured using the tracer incorporation technique with L-[ring-(13)C(6)]-phenylalanine. The experimental group (n = 13) received a medical food containing 40 g protein, based on casein and whey protein and enriched with 10% free leucine and other specific components, while the control group (n = 12) was given a conventionally used medical food based on casein protein alone (24 g). Blood and muscle samples were collected in the basal state and 5h hours after ingestion of the medical foods.
The cancer patients were in an inflammatory state, as reflected by high levels of C-reactive protein (CRP), IL-1 β and TNF-α, but were not insulin resistant (HOMA). After ingestion of the experimental medical food, plasma leucine increased to about 400 μM as compared to the peak value of 200 μM, after the control medical food (p < 0.001). Ingestion of the experimental medical food increased muscle protein FSR from 0.073 (SD: 0.023) to 0.097 (SD: 0.033) %/h (p = 0.0269). In contrast, ingestion of the control medical food did not increase muscle FSR; 0.073 (SD: 0.022) and 0.065 (SD: 0.028) %/h.
In cancer patients, conventional nutritional supplementation is ineffective in stimulating muscle protein synthesis. This anabolic resistance can be overcome with a specially formulated nutritional supplement.
维持肌肉质量对于改善癌症患者的预后和生活质量至关重要。刺激肌肉蛋白合成是维持肌肉质量的代谢基础,但在癌症患者中,正常饮食摄入对肌肉蛋白合成的影响很小。向高蛋白补充剂中添加亮氨酸可刺激健康老年人的肌肉蛋白合成。本研究旨在确定一种特别配方的高亮氨酸和高蛋白医学食品是否比传统医学食品更能急性刺激癌症患者的肌肉蛋白合成。
在有影像学证据的癌症患者 25 例中采用随机、对照、双盲、平行组设计。在开始癌症治疗前或完成或停止治疗后 4 周时对患者进行研究。使用 L-[环-(13)C(6)]-苯丙氨酸示踪剂掺入技术测量肌肉蛋白合成的分数率(FSR)。实验组(n=13)接受含有 40 g 蛋白质的医学食品,基于酪蛋白和乳清蛋白,并富含 10%游离亮氨酸和其他特定成分,而对照组(n=12)给予仅基于酪蛋白蛋白的常规使用的医学食品(24 g)。在基础状态和摄入医学食品后 5 小时采集血液和肌肉样本。
癌症患者处于炎症状态,反映在 C 反应蛋白(CRP)、IL-1β和 TNF-α 水平升高,但无胰岛素抵抗(HOMA)。与对照医学食品(p<0.001)相比,摄入实验性医学食品后,血浆亮氨酸增加到约 400 μM,峰值为 200 μM。摄入实验性医学食品可使肌肉蛋白 FSR 从 0.073(SD:0.023)增加到 0.097(SD:0.033)%/h(p=0.0269)。相比之下,摄入对照医学食品不会增加肌肉 FSR;分别为 0.073(SD:0.022)和 0.065(SD:0.028)%/h。
在癌症患者中,常规营养补充对刺激肌肉蛋白合成无效。这种合成代谢抵抗可以通过特别配方的营养补充来克服。